On the occasion of World Prostate Cancer Day, celebrated on June 11th, ROC Clinic held the 1st Prostate Cancer Forum in collaboration with the newspaper La Razón at the newspaper’s headquarters last Wednesday at 17:30. The event is available online for those who wish to watch it later through this link.
The newsletter supplement “A Tu Salud” was in charge to cover the main conclusions of the gathering, where doctors, patient associations and patients with previous diagnosis came together to discuss the importance of early detection, treatments, and the needs of patients with this pathology.
The event began with the welcome speech of the newspaper director, Francisco Marhuenda followed by the intervention of the director of the Urology Department in HM Hospitals and the Medical Director of ROC Clinic, Dr. Javier Romero-Otero, who was in charge to moderate the first panel of experts, which included doctors Alfredo Rodriguez Antolín, Head of the Urology Department at Hospital Universitario 12 de Octubre; Karim Touijer, prostate cancer expert at Memorial Sloan Kettering Cancer Center in New York and Juan Francisco Rodriguez Moreno, coordinator of the Prostate Cancer and Melanoma Area at HM CIOCC.
During our interventions we highlighted the importance of raising awareness among the male population related to the significance of annual check-ups because, in the case of a prostate cancer diagnosis, we currently have a variety of customized solutions for each specific case, along with a multidisciplinary team.
Subsequently, there was a second panel of patients formed by interventions from Ana Isabel González Márquez, head of the Service and Programs Area of the Asociación Española Contra el Cáncer (AECC); Marcos Martínez Cortéz, manager of GEPAC; Santiago Gómez Díaz, first vice-president of ANCAP, and Félix Alonso Navas, prostate cancer patient.
In the second part of the venue, associations and patients expressed their needs and points of view regarding the disease, openly addressing the taboo that currently around discussing prostate cancer and its emotional, functional, and sexual consequences.
